Aspirin for the prevention of colorectal cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 4-5, 2011, Pages 461-472

  Garcia Albeniz, X ^a   Chan, A T ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Adenoma; Aspirin; Colorectal cancer; NSAID

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; ROFECOXIB;

BRAIN HEMORRHAGE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RECURRENCE; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL CARCINOMA; DISEASE FREE SURVIVAL; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HIGH RISK POPULATION; HUMAN; LOW DRUG DOSE; META ANALYSIS (TOPIC); OPTIMAL DRUG DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM POLYP; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; VASCULAR DISEASE;

EID: 82455162845     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.10.015     Document Type: Article

References (84)

1. GLOBOCAN [Internet]. [cited 2011 Oct 4];Available from: http://globocan.iarc.fr 2008
2. J.A. Shapiro, L.C. Seeff, and T.D. Thompson Colorectal cancer test use from the 2005 National Health Interview Survey Cancer Epidemiology, Biomarkers & Prevention 17 7 2008 Jul 1623 1630
3. US Preventive Services Task Force Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement Annals of Internal Medicine 149 9 2008 Nov 4 627 637
4. E. Flossmann, and P.M. Rothwell Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies Lancet 369 9573 2007 May 12 1603 1613 (Pubitemid 46710123)
5. M.J. Thun, M.M. Namboodiri, and C.W. Heath Aspirin use and reduced risk of fatal colon cancer The New England Journal of Medicine 325 23 1991 Dec 5 1593 1596
6. E.J. Jacobs, M.J. Thun, and E.B. Bain A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence The New England Journal of Medicine 99 8 2007 Apr 18 608 615 (Pubitemid 47073542)
7. A.T. Chan, E.L. Giovannucci, and J.A. Meyerhardt Aspirin dose and duration of use and risk of colorectal cancer in men Gastroenterology 134 1 2008 Jan 21 28 (Pubitemid 350309311)
8. A.T. Chan, E.L. Giovannucci, and J.A. Meyerhardt Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer JAMA 294 8 2005 Aug 24 914 923 (Pubitemid 41215460)
9. E.H. Ruder, A.O. Laiyemo, and B.I. Graubard Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort The American Journal of Gastroenterology 106 7 2011 Jul 1340 1350
10. A.T. Chan, J.E. Manson, and D. Feskanich Long-term aspirin use and mortality in women Archives of Internal Medicine 167 6 2007 Mar 26 562 572 (Pubitemid 46513225)
11. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin use and survival after diagnosis of colorectal cancer JAMA 302 6 2009 Aug 12 649 658
12. C. Fuchs, J.A. Meyerhardt, and D.L. Heseltine Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from Intergroup trial CALGB 89803 Journal of Clinical Oncology 23 16S 2005 3530
13. A.E. Coghill, P.A. Newcomb, and P.T. Campbell Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer Gut 60 4 2011 Apr 491 498
14. J.A. Zell, A. Ziogas, and L. Bernstein Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis Cancer 115 24 2009 Dec 15 5662 5671
15. P.M. Rothwell, M. Wilson, and C.-E. Elwin Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Lancet 376 9754 2010 Nov 20 1741 1750
16. R. Peto, R. Gray, and R. Collins Randomised trial of prophylactic daily aspirin in British male doctors British Medical Journal (Clinical Research Ed.) 296 6618 1988 Jan 30 313 316 (Pubitemid 18042841)
17. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Lancet 351 9098 1998 Jan 24 233 241
18. The SALT Collaborative Group Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events Lancet 338 8779 1991 Nov 30 1345 1349
19. B. Farrell, J. Godwin, and S. Richards The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results Journal of Neurology, Neurosurgery, and Psychiatry 54 12 1991 Dec 1044 1054
20. P.M. Rothwell, F.G.R. Fowkes, and J.F.F. Belch Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 9759 2011 Jan 1 31 41
21. ETDRS Investigators Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14 JAMA 268 10 1992 Sep 9 1292 1300
22. S. Juul-Möller, N. Edvardsson, and B. Jahnmatz Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group Lancet 340 8833 1992 Dec 12 1421 1425
23. H. Ogawa, M. Nakayama, and T. Morimoto Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JAMA 300 18 2008 Nov 12 2134 2141
24. J. Belch, A. MacCuish, and I. Campbell The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease BMJ 337 2008 Jan a1840
25. F.G.R. Fowkes, J.F. Price, and M.C.W. Stewart Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial JAMA 303 9 2010 Mar 3 841 848
26. Steering Commitee of the Physicians' Health Study Research Group Final report on the aspirin component of the ongoing Physicians' Health Study The New England Journal of Medicine 321 3 1989 129 135
27. P.M. Ridker, N.R. Cook, and I.-M. Lee A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women The New England Journal of Medicine 352 13 2005 Mar 31 1293 1304
28. N.R. Cook, I.-M. Lee, and J.M. Gaziano Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 1 2005 Jul 6 47 55 (Pubitemid 41002838)
29. P.H. Gann, J.E. Manson, and R.J. Glynn Low-dose aspirin and incidence of colorectal tumors in a randomized trial The New England Journal of Medicine 85 15 1993 Aug 4 1220 1224 (Pubitemid 23223527)
30. R.S. Sandler, S. Halabi, and J.A. Baron A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer The New England Journal of Medicine 348 10 2003 Mar 6 883 890 (Pubitemid 36297996)
31. J.A. Baron, B.F. Cole, and R.S. Sandler A randomized trial of aspirin to prevent colorectal adenomas The New England Journal of Medicine 348 10 2003 Mar 6 891 899 (Pubitemid 36297997)
32. R. Benamouzig, J. Deyra, and A. Martin Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial Gastroenterology 125 2 2003 Aug 328 336 (Pubitemid 36929412)
33. R.F.A. Logan, M.J. Grainge, and V.C. Shepherd Aspirin and folic acid for the prevention of recurrent colorectal adenomas Gastroenterology 134 1 2008 Jan 29 38 (Pubitemid 350309319)
34. B.F. Cole, R.F. Logan, and S. Halabi Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials The New England Journal of Medicine 101 4 2009 Feb 18 256 266
35. R. Benamouzig, B. Uzzan, and J. Deyra Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial Gut 2011 Sep 2
36. H. Ishikawa, T. Nakamura, and A. Kawano Chemoprevention of colorectal cancer in Japan: a brief introduction to current clinical trials Journal of Gastroenterology 44 Suppl. 1 2009 Jan 77 81
37. P. Galiatsatos, and W.D. Foulkes Familial adenomatous polyposis The American Journal of Gastroenterology 101 2 2006 Feb 385 398 (Pubitemid 43381685)
38. F.M. Giardiello, S.R. Hamilton, and A.J. Krush Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis The New England Journal of Medicine 328 18 1993 May 6 1313 1316 (Pubitemid 23131373)
39. G. Steinbach, P.M. Lynch, and R.K. Phillips The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis The New England Journal of Medicine 342 26 2000 Jun 29 1946 1952 (Pubitemid 30419089)
40. A. Hallak, L. Alon-Baron, and R. Shamir Rofecoxib reduces polyp recurrence in familial polyposis Digestive Diseases and Sciences 48 10 2003 Oct 1998 2002 (Pubitemid 37410090)
41. J. Burn, D.T. Bishop, and P.D. Chapman A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis Cancer Prevention Research (Philadelphia, Pa.) 4 5 2011 May 655 665
42. H.T. Lynch, P.M. Lynch, and S.J. Lanspa Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications Clinical Genetics 76 1 2009 Jul 1 18
43. J. Burn, D.T. Bishop, and J.-P. Mecklin Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome The New England Journal of Medicine 359 24 2008 Dec 11 2567 2578
44. Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet, in press.
45. A. Mahipal, K.E. Anderson, and P.J. Limburg Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study Cancer Epidemiology, Biomarkers & Prevention 15 10 2006 Oct 1785 1790 (Pubitemid 44664249)
46. J. Cuzick, F. Otto, and J.A. Baron Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement The Lancet Oncology 10 5 2009 May 501 507
47. C.C. Johnson, R.B. Hayes, and R.E. Schoen Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial The American Journal of Gastroenterology 105 12 2010 Dec 2646 2655
48. F.V.N. Din, E. Theodoratou, and S.M. Farrington Effect of aspirin and NSAIDs on risk and survival from colorectal cancer Gut 59 12 2010 Dec 1670 1679
49. Kune GA. The Melbourne Colorectal Cancer Study: reflections on a 30-year experience. The Medical Journal of Australia. 193(11-12):648-652.
50. C. Sostres, and A. Lanas Gastrointestinal effects of aspirin Nature Reviews Gastroenterology & Hepatology 8 7 2011 Jan 385 394
51. C. Patrono, C. Baigent, and J. Hirsh Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 133 6 Suppl 2008 Jun 199S 233S (8th Edition) (Pubitemid 351894914)
52. A. Lanas, P. Wu, and J. Medin Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis Clinical Gstroenterology and Hepatology 9 9 2011 Sep 762 768 e6
53. V.L. Serebruany, S.R. Steinhubl, and P.B. Berger Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials The American Journal of Cardiology 95 10 2005 May 15 1218 1222 (Pubitemid 40616424)
54. R.J.G. Peters, S.R. Mehta, and K.A.A. Fox Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study Circulation 108 14 2003 Oct 7 1682 1687 (Pubitemid 37243654)
55. E.J. Topol, D. Easton, and R.A. Harrington Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease Circulation 108 4 2003 Jul 29 399 406 (Pubitemid 36935531)
56. S. Derry, and Y.K. Loke Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis BMJ 321 7270 2000 Nov 11 1183 1187
57. K.R. McQuaid, and L. Laine Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials The American Journal of Medicine 119 8 2006 Aug 624 638 (Pubitemid 44128438)
58. S.R. Steinhubl, D.L. Bhatt, and D.M. Brennan Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding Annals of Internal Medicine 150 6 2009 Mar 17 379 386
59. The Dutch TIA Trial Study Group A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke The New England Journal of Medicine 325 18 1991 Oct 31 1261 1266
60. P.J. Roderick, H.C. Wilkes, and T.W. Meade The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials British Journal of Clinical Pharmacology 35 3 1993 Mar 219 226 (Pubitemid 23074044)
61. E.S. Huang, L.L. Strate, and W.W. Ho A prospective study of aspirin use and the risk of gastrointestinal bleeding in men PloS One 5 12 2010 Jan e15721
62. E.S. Huang, L.L. Strate, and W.W. Ho Long-term use of aspirin and the risk of gastrointestinal bleeding The American Journal of Medicine 124 5 2011 May 426 433
63. J. Weil, D. Colin-Jones, and M. Langman Prophylactic aspirin and risk of peptic ulcer bleeding BMJ 310 6983 1995 Apr 1 827 830
64. P.B. Gorelick, and S.M. Weisman Risk of hemorrhagic stroke with aspirin use: an update Stroke 36 8 2005 Aug 1801 1807 (Pubitemid 41098782)
65. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement Annals of Internal Medicine 146 5 2007 Mar 6 361 364
66. C. Patrono, L.A. García Rodríguez, and R. Landolfi Low-dose aspirin for the prevention of atherothrombosis The New England Journal of Medicine 353 22 2005 Dec 1 2373 2383 (Pubitemid 41713749)
67. A. Greenhough, H.J.M. Smartt, and A.E. Moore The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 3 2009 Mar 377 386
68. D. Wang, and R.N. Dubois Prostaglandins and cancer Gut 55 1 2006 Jan 115 122 (Pubitemid 41820645)
69. P.C. Chulada, M.B. Thompson, and J.F. Mahler Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice Cancer Research 60 17 2000 Sep 1 4705 4708
70. Patrono C. Measurement of cyclooxygenase isozyme inhibition in humans: exploring the clinical relevance of biochemical selectivity. Clinical and Experimental Rheumatology. 19(6 Suppl. 25):S45-S50.
71. M.T. Ruffin, K. Krishnan, and C.L. Rock Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose Journal of the National Cancer Institute 89 15 1997 Aug 6 1152 1160 (Pubitemid 27337930)
72. P.C. Chulada, C.D. Loftin, and V.D. Winn Relative activities of retrovirally expressed murine prostaglandin synthase-1 and -2 depend on source of arachidonic acid Archives of Biochemistry and Biophysics 330 2 1996 Jun 15 301 313 (Pubitemid 26172366)
73. B.S. Reddy, C.V. Rao, and K. Seibert Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis Cancer Research 56 20 1996 Oct 15 4566 4569 (Pubitemid 26338047)
74. M. Oshima, J.E. Dinchuk, and S.L. Kargman Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 5 1996 Nov 29 803 809 (Pubitemid 26404280)
75. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 The New England Journal of Medicine 356 21 2007 May 24 2131 2142 (Pubitemid 47010839)
76. J. Clria, M.H. Lee, and C.N. Serhan Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation Molecular Medicine 2 5 1996 Sep 583 596 (Pubitemid 26353107)
77. P.A. Craven, and F.R. DeRubertis Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis Carcinogenesis 13 4 1992 Apr 541 546
78. C. Patrono, P. Patrignani, and L.A. García Rodríguez Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs The Journal of Clinical Investigation 108 1 2001 Jul 7 13 (Pubitemid 32634915)
79. T. Ulrych, A. Böhm, and A. Polzin Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation Journal of Thrombosis and Haemostasis 9 4 2011 Apr 790 798
80. N.J. Pyne, and S. Pyne Sphingosine 1-phosphate and cancer Nature Reviews. Cancer 10 7 2010 Jul 489 503
81. N. Babbar, E.W. Gerner, and R.A. Casero Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells The Biochemical Journal 394 1 2006 Feb 15 317 324 (Pubitemid 43259681)
82. Martinez ME, O'Brien TG, Fultz KE, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proceedings of the National Academy of Sciences of the United States of America. 2003 Jun 24;100(13):7859-7864.
83. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement Annals of Internal Medicine 150 6 2009 Mar 17 396 404
84. Hassan C, Rex DK, Cooper GS, et al. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis. Gut, in press.